The Investor Relations website contains information about Sana Biotechnology, Inc's business for stockholders, potential investors, and financial analysts.| Sana Biotechnology, Inc
Data Demonstrate that Sana’s Hypoimmune (HIP)-Modified Pancreatic Islet Cells, Transplanted with No Immunosuppression, Persist and Function Over Time in Patient with Type 1 Diabetes Study Establishes Ability to Genetically Modify and Transplant Pancreatic Islet Cells Without Immunosuppression and| Sana Biotechnology, Inc